NASDAQ:ALDX
Aldeyra Therapeutics Stock News
$3.93
-0.0100 (-0.254%)
At Close: Apr 26, 2024
Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
10:46am, Monday, 22'nd Apr 2024
Here is how Aldeyra Therapeutics, Inc. (ALDX) and Inspire Medical Systems (INSP) have performed compared to their sector so far this year.
Buffett Grabs More of This Stock, Plus Other Notable Insider Buying
08:45am, Sunday, 21'st Apr 2024
At the end of the previous week, the Oracle of Omaha yet again boosted his stake in a media giant's tracking stocks, even with shares still in retreat.
Insiders Scoop Up Shares of These 5 Stocks for the Second Quarter
08:55am, Sunday, 07'th Apr 2024
Although the number and size of insider purchases have been somewhat lower as the second quarter begins, the following beneficial owners and other insiders were still showing their love for these five
Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
07:41am, Saturday, 06'th Apr 2024
Aldeyra (ALDX) rises 43% in one week, driven by plans to initiate a pivotal study to support the resubmission of reproxalap NDA for dry eye disease in the first half of 2024.
Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie
12:46am, Sunday, 24'th Mar 2024
Lead asset, reproxalap, has clear path to regulatory approval in Dry Eye Disease. Option deal for commercial license with AbbVie signed - $400M in milestones, 60/40 profit shares of US market and tier
Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
10:41am, Wednesday, 06'th Mar 2024
Here, we discuss some reasons why investing in Aldeyra Therapeutics (ALDX) stock now may turn out to be a prudent move.
5 Small Drug Stocks to Buy From a Rebounding Industry
09:56am, Thursday, 29'th Feb 2024
Innovation is expected to continue to drive growth of the Medical-Drugs industry. UTHR, ESPR, HRTX, LYRA and ALDX may prove to be good additions to one's portfolio.
Why Aldeyra Therapeutics Is A Strong Buy: AbbVie Agreement And Reproxalap's Prospects
02:56am, Sunday, 28'th Jan 2024
Aldeyra Therapeutics is a biotech company focused on developing treatments for immune-mediated inflammatory diseases, with its leading drug candidate being Reproxalap for dry eye and allergic conjunct
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced it will host a webcast and conference call on Tuesday, December 19, 2023, at 8:00 a.m. (ET) to pr
Should You Buy Aldeyra Therapeutics (ALDX) Ahead of Earnings?
10:32am, Tuesday, 05'th Dec 2023
Aldeyra Therapeutics (ALDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BOX Gears Up to Report Q3 Earnings: What's in the Offing?
01:32pm, Friday, 01'st Dec 2023
BOX's fiscal third-quarter results are likely to reflect strength in content cloud solutions.
Invest In Penny Stocks? Is It Worth It & 4 To Watch Now
02:12pm, Tuesday, 07'th Nov 2023
If you're looking for penny stocks to invest in right now, you've got your work cut out for you. That's because the initial strategy when approaching cheap stocks is to trade them in the short term in
5 Most Active Penny Stocks Today & Why They're Moving Now
02:11pm, Wednesday, 01'st Nov 2023
Penny stocks are the wild west of the stock market. Fast-paced, unpredictable, and laden with potential treasures.
Why Are Stocks Up Today?
10:47am, Wednesday, 01'st Nov 2023
Stocks are up today as investors prepare for the latest information from the Federal Reserve concerning interest rates. The Federal Open Market Committee (FOMC) meeting taking place today will result
Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today?
10:34am, Wednesday, 01'st Nov 2023
Aldeyra Therapeutics (NASDAQ: ALDX ) stock is on the rise Wednesday after entering into an exclusive option agreement with AbbVie (NYSE: ABBV ). This agreement covers the option for AbbVie to acquire